The impact of interaction between verteporfin and yes-associated protein 1/transcriptional coactivator with PDZ-binding motif-TEA domain pathway on the progression of isocitrate dehydrogenase wild-type glioblastoma

Verteporfin and 5-ALA are used for visualizing malignant tissue components in different body tumors and as photodynamic therapy in treating isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM). Additionally, verteporfin interferes with Yes-associated protein 1 (YAP)/Transcriptional coactivato...

Full description

Bibliographic Details
Main Authors: Mahmoud Osama MD, Muhammed Amir Essibayi MD, Mona Osama B Pharm, Ismail A. Ibrahim, Mostafa Nasr Mostafa MD, Murat Şakir Ekşi MD
Format: Article
Language:English
Published: SAGE Publishing 2023-08-01
Series:Journal of Central Nervous System Disease
Online Access:https://doi.org/10.1177/11795735231195760